
Sign up to save your podcasts
Or


Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.
By Dr. Karim Ladak5
181181 ratings
Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.

1,864 Listeners

499 Listeners

51 Listeners

124 Listeners

3,350 Listeners

119 Listeners

8,597 Listeners

119 Listeners

196 Listeners

516 Listeners

368 Listeners

69 Listeners

189 Listeners

272 Listeners

20 Listeners